Spyridon Artavanis-Tsakonas
Founder bei Fondation Santé
Profil
Spyridon Artavanis-Tsakonas is the founder of Cellzome Ltd.
(founded in 2000).
Dr. Artavanis-Tsakonas is also the founder of Anadys Pharmaceuticals, Inc., Exelixis Pharmaceuticals, Inc., Cellzome, Inc., and Fondation Santé.
Dr. Artavanis-Tsakonas's current job(s) include being the Director at BrainTale SAS (since 2021) and an Associate Member at the European Molecular Biology Organization.
Dr. Artavanis-Tsakonas's former job(s) include being the Founding Director at Institut Curie (2007-2009), Chief Scientific Officer & Executive VP at Biogen, Inc., and a Professor at the Massachusetts General Hospital Cancer Center (1999-2007).
Dr. Artavanis-Tsakonas's education includes a doctorate from the University of Cambridge and a graduate degree from the Swiss Federal Institute of Technology.
Aktive Positionen von Spyridon Artavanis-Tsakonas
| Unternehmen | Position | Beginn |
|---|---|---|
| Harvard Medical School | Corporate Officer/Principal | 01.01.1999 |
| Fondation Santé | Founder | - |
BrainTale SAS
 BrainTale SAS Packaged SoftwareTechnology Services BrainTale SAS engages in the development and distribution of diagnosis and prognosis tools for brain injured patients. Its products include BrainQuant and BrainScore-coma. The company was founded by Vincent Perlbarg, Julie Rachline, Didier Cassereau, Louis Puybasset, Damien Galanaud, and Lionel Velly on July 6, 2018 and is headquartered in Paris, France. | Director/Board Member | 03.06.2021 |
| European Molecular Biology Organization | Corporate Officer/Principal | - |
Cambridge Philosophical Society
 Cambridge Philosophical Society Investment Trusts/Mutual FundsMiscellaneous The Cambridge Philosophical Society provides grant making services. | Corporate Officer/Principal | - |
| Academy of Athens | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Spyridon Artavanis-Tsakonas
| Unternehmen | Position | Ende |
|---|---|---|
| BIOGEN INC. | Chief Tech/Sci/R&D Officer | 01.03.2017 |
Institut Curie
 Institut Curie Miscellaneous Commercial ServicesCommercial Services Institut Curie engages as a non-profit foundation. It operates a research center on biophysics, cell biology, and oncology and a hospital specialized in treatment of cancer. The company was founded in 1909 and is headquartered in Paris, France. | Director/Board Member | 01.01.2009 |
Massachusetts General Hospital Cancer Center
 Massachusetts General Hospital Cancer Center Hospital/Nursing ManagementHealth Services Massachusetts General Hospital Cancer Center operates as cancer treatment center. The company was founded by John Warren in 1811 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01.01.2007 |
| ░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - |
| ░░░░░░░░ ░░░░ | ░░░░░░░ | - |
Ausbildung von Spyridon Artavanis-Tsakonas
| University of Cambridge | Doctorate Degree |
| Swiss Federal Institute of Technology | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BIOGEN INC. | Health Technology |
| Private Unternehmen | 11 |
|---|---|
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Health Technology |
Cellzome Ltd.
 Cellzome Ltd. Pharmaceuticals: MajorHealth Technology Cellzome Ltd. engages in the research, development, and manufacture of pharmaceutical products. It provides kinase-targeted drugs to treat inflammatory diseases. The company was founded by Gitte Neubauer on December 22, 2003 and is headquartered in Middlesex, the United Kingdom. | Health Technology |
| Exelixis Pharmaceuticals, Inc. | Health Technology |
Massachusetts General Hospital Cancer Center
Massachusetts General Hospital Cancer Center Hospital/Nursing ManagementHealth Services Massachusetts General Hospital Cancer Center operates as cancer treatment center. The company was founded by John Warren in 1811 and is headquartered in Boston, MA. | Health Services |
| Fondation Santé | |
| European Molecular Biology Organization | |
Institut Curie
Institut Curie Miscellaneous Commercial ServicesCommercial Services Institut Curie engages as a non-profit foundation. It operates a research center on biophysics, cell biology, and oncology and a hospital specialized in treatment of cancer. The company was founded in 1909 and is headquartered in Paris, France. | Commercial Services |
Cellzome, Inc.
 Cellzome, Inc. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Cellzome, Inc. develops immune-inflammation therapy. The private company is based in Philadelphia, PA. The company was founded by Spyridon Artavanis-Tsakonas, Stelios Papadopoulos. | Health Technology |
Cambridge Philosophical Society
Cambridge Philosophical Society Investment Trusts/Mutual FundsMiscellaneous The Cambridge Philosophical Society provides grant making services. | Miscellaneous |
| Academy of Athens | |
BrainTale SAS
BrainTale SAS Packaged SoftwareTechnology Services BrainTale SAS engages in the development and distribution of diagnosis and prognosis tools for brain injured patients. Its products include BrainQuant and BrainScore-coma. The company was founded by Vincent Perlbarg, Julie Rachline, Didier Cassereau, Louis Puybasset, Damien Galanaud, and Lionel Velly on July 6, 2018 and is headquartered in Paris, France. | Technology Services |
